SYNH ALERT The Klein Law Firm Announces a Lead Plaintiff Deadline of September 25, 2023 in the Class Action Filed on Behalf of Syneos Health, Inc. Shareholders
SYNHDelisted Stock | USD 42.31 0.07 0.17% |
Under 61% of Syneos Health's investor base is looking to short. The analysis of current outlook of investing in Syneos Health suggests that many traders are alarmed regarding Syneos Health's prospects. Syneos Health's investing sentiment shows overall attitude of investors towards Syneos Health.
Syneos |
NEW YORK, Aug. 16, 2023 The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Syneos Health, Inc. alleging that the Company violated
Read at benzinga.com
Syneos Health Fundamental Analysis
We analyze Syneos Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Syneos Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Syneos Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Syneos Health is currently under evaluation in target price category among its peers.
Syneos Health Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Syneos Health stock to make a market-neutral strategy. Peer analysis of Syneos Health could also be used in its relative valuation, which is a method of valuing Syneos Health by comparing valuation metrics with similar companies.
Peers
Syneos Health Related Equities
MEDP | Medpace Holdings | 1.65 | ||||
SHC | Sotera Health | 1.52 | ||||
MTD | Mettler Toledo | 0.50 | ||||
CRL | Charles River | 0.37 | ||||
MYGN | Myriad Genetics | 0.07 | ||||
IQV | IQVIA Holdings | 0.35 | ||||
QGEN | Qiagen NV | 0.43 | ||||
RDNT | RadNet | 0.58 | ||||
LH | Laboratory | 0.64 | ||||
NEOG | Neogen | 1.81 | ||||
ICLR | ICON PLC | 2.38 | ||||
ACRS | Aclaris Therapeutics | 7.63 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Syneos Stock
If you are still planning to invest in Syneos Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Syneos Health's history and understand the potential risks before investing.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |